Tapewire

Nasdaq · USD

SUPN

SUPERNUS PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
4333
SEC CIK
0001356576
Parsed reports
400

Last 12 months

Inside the activity.

0 purchase rows · 20 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202600
Feb 202602
Mar 2026015
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 12, 2026 Filed Aug 14, 2026 21:11 UTC
Rubin JonathanSVP, Chief Medical Officer
Exercise / conversionPerformance Share Unit · Derivative 750 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001836067-26-000010 · wk-form4_1786741908.xml · derivative · entry 3

Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

F3 · derivative.expiration_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:11 UTC
Rubin JonathanSVP, Chief Medical Officer
Tax withholdingCommon Stock 363 $46.57 $16,904.91
Disclosure

SEC source: 0001836067-26-000010 · wk-form4_1786741908.xml · nonDerivative · entry 2

Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,979

F2 · kind: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:11 UTC
Rubin JonathanSVP, Chief Medical Officer
Exercise / conversionCommon Stock 750 $0.00 $0.00
Disclosure

SEC source: 0001836067-26-000010 · wk-form4_1786741908.xml · nonDerivative · entry 1

Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,342

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:10 UTC
Mottola FrankSVP, Chief Tech. Ops. Officer
Exercise / conversionPerformance Share Unit · Derivative 1,650 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001804567-26-000014 · wk-form4_1786741823.xml · derivative · entry 3

Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,650 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

F3 · derivative.expiration_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:10 UTC
Mottola FrankSVP, Chief Tech. Ops. Officer
Tax withholdingCommon Stock 797 $46.57 $37,116.29
Disclosure

SEC source: 0001804567-26-000014 · wk-form4_1786741823.xml · nonDerivative · entry 2

Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,544

F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:10 UTC
Mottola FrankSVP, Chief Tech. Ops. Officer
Exercise / conversionCommon Stock 1,650 $0.00 $0.00
Disclosure

SEC source: 0001804567-26-000014 · wk-form4_1786741823.xml · nonDerivative · entry 1

Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,341

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:09 UTC
DEC TIMOTHY CSenior Vice-President & CFO
Exercise / conversionPerformance Share Unit · Derivative 1,250 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001194020-26-000015 · wk-form4_1786741773.xml · derivative · entry 3

DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

F3 · derivative.expiration_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:09 UTC
DEC TIMOTHY CSenior Vice-President & CFO
Tax withholdingCommon Stock 604 $46.57 $28,128.28
Disclosure

SEC source: 0001194020-26-000015 · wk-form4_1786741773.xml · nonDerivative · entry 2

DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,129

F2 · kind: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:09 UTC
DEC TIMOTHY CSenior Vice-President & CFO
Exercise / conversionCommon Stock 1,250 $0.00 $0.00
Disclosure

SEC source: 0001194020-26-000015 · wk-form4_1786741773.xml · nonDerivative · entry 1

DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,733

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:12 UTC
Khattar Jack A.Director · President, CEO
Exercise / conversionPerformance Share Unit · Derivative 29,849 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001539937-26-000012 · wk-form4_1786741940.xml · derivative · entry 4

Khattar Jack A. · CIK 0001539937 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,849 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

F2 · derivative.expiration_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:12 UTC
Khattar Jack A.Director · President, CEO
Tax withholdingCommon Stock 12,642 $46.57 $588,737.94
Disclosure

SEC source: 0001539937-26-000012 · wk-form4_1786741940.xml · nonDerivative · entry 2

Khattar Jack A. · CIK 0001539937 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,258,351

F1 · kind: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:12 UTC
Khattar Jack A.Director · President, CEO
Exercise / conversionCommon Stock 29,849 $0.00 $0.00
Disclosure

SEC source: 0001539937-26-000012 · wk-form4_1786741940.xml · nonDerivative · entry 1

Khattar Jack A. · CIK 0001539937 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,270,993

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:11 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionPerformance Share Unit · Derivative 2,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001539215-26-000012 · wk-form4_1786741874.xml · derivative · entry 3

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

F3 · derivative.expiration_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:11 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Tax withholdingCommon Stock 1,158 $46.57 $53,928.06
Disclosure

SEC source: 0001539215-26-000012 · wk-form4_1786741874.xml · nonDerivative · entry 2

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,637

F2 · kind: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 21:11 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001539215-26-000012 · wk-form4_1786741874.xml · nonDerivative · entry 1

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,795

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:04 UTC
Rubin JonathanSVP, Chief Medical Officer
GrantPerformance Share Unit · Derivative 750 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001836067-26-000008 · wk-form4_1785531841.xml · derivative · entry 1

Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750

Underlying: Common Stock · 750 shares

Expires not disclosed

F1 · derivative.exercise_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

F1 · derivative.expiration_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:05 UTC
Mottola FrankSVP, Chief Tech. Ops. Officer
GrantPerformance Share Unit · Derivative 1,650 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001804567-26-000012 · wk-form4_1785531908.xml · derivative · entry 1

Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,650

Underlying: Common Stock · 1,650 shares

Expires not disclosed

F1 · derivative.exercise_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

F1 · derivative.expiration_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:05 UTC
DEC TIMOTHY CSenior Vice-President & CFO
GrantPerformance Share Unit · Derivative 1,250 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001194020-26-000013 · wk-form4_1785531954.xml · derivative · entry 1

DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires not disclosed

F1 · derivative.exercise_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

F1 · derivative.expiration_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:06 UTC
Khattar Jack A.Director · President, CEO
GrantPerformance Share Unit · Derivative 29,849 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001539937-26-000010 · wk-form4_1785531995.xml · derivative · entry 1

Khattar Jack A. · CIK 0001539937 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,849

Underlying: Common Stock · 29,849 shares

Expires not disclosed

F1 · derivative.exercise_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

F1 · derivative.expiration_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:04 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
GrantPerformance Share Unit · Derivative 2,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001539215-26-000010 · wk-form4_1785531875.xml · derivative · entry 1

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires not disclosed

F1 · derivative.exercise_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

F1 · derivative.expiration_date: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.

Read SEC document
March 18, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 7,250 $0.00 Strike: $39.40 $0.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · derivative · entry 22

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,250 shares

Expires 2028-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F11 · derivative.exercise_date: The option vested in four equal annual installments beginning on February 14, 2019.

Read SEC document
March 18, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
SaleCommon Stock 412 $50.48 $20,797.76
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 14

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,044

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

Read SEC document
March 18, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
SaleCommon Stock 6,838 $49.55 $338,822.90
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 13

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,456

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.40 to $49.99. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
March 18, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionCommon Stock 7,250 $39.40 $285,650.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 12

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,294

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

Read SEC document
March 17, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $38.60 $0.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · derivative · entry 21

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 15,000 shares

Expires 2033-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F12 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 23, 2024.

Read SEC document
March 17, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 12,250 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · derivative · entry 20

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,250 shares

Expires 2029-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F7 · derivative.exercise_date: The option vested in four equal annual installments beginning on February 22, 2020.

Read SEC document
March 17, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 22,750 $0.00 Strike: $39.40 $0.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · derivative · entry 19

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,250

Underlying: Common Stock · 22,750 shares

Expires 2028-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F11 · derivative.exercise_date: The option vested in four equal annual installments beginning on February 14, 2019.

Read SEC document
March 17, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
SaleCommon Stock 22,290 $50.73 $1,130,771.70
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 11

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,044

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.40 to $51.15. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
March 17, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
SaleCommon Stock 27,710 $49.95 $1,384,114.50
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 10

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,334

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.40 to $50.39. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
March 17, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionCommon Stock 15,000 $38.60 $579,000.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 9

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,044

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

Read SEC document
March 17, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionCommon Stock 12,250 $36.75 $450,187.50
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 8

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,044

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

Read SEC document
March 17, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionCommon Stock 22,750 $39.40 $896,350.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 7

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,794

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $27.94 $0.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · derivative · entry 18

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 5,000 shares

Expires 2034-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F10 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2025.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $32.20 $0.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · derivative · entry 17

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,000 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F9 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2023.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 4,250 $0.00 Strike: $29.61 $0.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · derivative · entry 16

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,250 shares

Expires 2031-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F8 · derivative.exercise_date: The option vested in four equal annual installments beginning on February 19, 2022.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 22,750 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · derivative · entry 15

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,250

Underlying: Common Stock · 22,750 shares

Expires 2029-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F7 · derivative.exercise_date: The option vested in four equal annual installments beginning on February 22, 2020.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
SaleCommon Stock 15,886 $50.49 $802,084.14
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 6

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,044

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.35 to $50.77. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
SaleCommon Stock 34,114 $50.18 $1,711,840.52
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 5

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,930

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.34 to $50.34. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionCommon Stock 5,000 $27.94 $139,700.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 4

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,044

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionCommon Stock 18,000 $32.20 $579,600.00
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 3

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,044

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionCommon Stock 4,250 $29.61 $125,842.50
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 2

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,044

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 21:18 UTC
Bhatt Padmanabh P.Sr. VP of IP, CSO
Exercise / conversionCommon Stock 22,750 $36.75 $836,062.50
Disclosure

SEC source: 0001539215-26-000008 · wk-form4_1773868712.xml · nonDerivative · entry 1

Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,794

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 20:08 UTC
Khattar Jack A.Director · President, CEO
SaleCommon Stock 120 $51.75 $6,210.00
Disclosure

SEC source: 0001539937-26-000008 · wk-form4_1773691696.xml · nonDerivative · entry 5

Khattar Jack A. · CIK 0001539937 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the KBT Trust

Disclosed balance after: 958,100

F2 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 20:08 UTC
Khattar Jack A.Director · President, CEO
SaleCommon Stock 10,742 $51.00 $547,842.00
Disclosure

SEC source: 0001539937-26-000008 · wk-form4_1773691696.xml · nonDerivative · entry 4

Khattar Jack A. · CIK 0001539937 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the KBT Trust

Disclosed balance after: 958,220

F2 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.63 to $51.54. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 20:08 UTC
Khattar Jack A.Director · President, CEO
SaleCommon Stock 24,138 $50.09 $1,209,072.42
Disclosure

SEC source: 0001539937-26-000008 · wk-form4_1773691696.xml · nonDerivative · entry 3

Khattar Jack A. · CIK 0001539937 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the KBT Trust

Disclosed balance after: 968,962

F2 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.63 to $50.62. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 20:08 UTC
Khattar Jack A.Director · President, CEO
OtherCommon Stock 12,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001539937-26-000008 · wk-form4_1773691696.xml · nonDerivative · entry 2

Khattar Jack A. · CIK 0001539937 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the KBT Trust

Disclosed balance after: 993,100

F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 12,500 shares were transferred from the KBT Trust to the Reporting Person on March 13, 2026 without consideration and are now owned directly.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 20:08 UTC
Khattar Jack A.Director · President, CEO
OtherCommon Stock 12,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001539937-26-000008 · wk-form4_1773691696.xml · nonDerivative · entry 1

Khattar Jack A. · CIK 0001539937 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,241,144

F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 12,500 shares were transferred from the KBT Trust to the Reporting Person on March 13, 2026 without consideration and are now owned directly.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 16:07 UTC SaleCommon Stock 5,369 $50.61 $271,725.09
Disclosure

SEC source: 0001438462-26-000006 · wk-form4_1773691657.xml · nonDerivative · entry 1

Hudson Frederick M. · CIK 0001438462 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,413

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.45 to $50.82. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc., any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
March 10, 2026 Filed Mar 10, 2026 20:12 UTC
Horich William ToddSVP, Commercial Operations
SaleCommon Stock 4,439 $55.00 $244,145.00
Disclosure

SEC source: 0002117599-26-000004 · wk-form4_1773173526.xml · nonDerivative · entry 8

Horich William Todd · CIK 0002117599 · SVP, Commercial Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
March 09, 2026 Filed Mar 10, 2026 20:13 UTC
Mottola FrankSVP, Chief Tech. Ops. Officer
SaleCommon Stock 1,623 $53.65 $87,073.95
Disclosure

SEC source: 0001804567-26-000010 · wk-form4_1773173598.xml · nonDerivative · entry 3

Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,440

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.